An observational study in Nasopharyngeal Carcinoma (NPC), sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Not yet recruiting. Open to participants aged 15 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-09-30.
Sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Observational
To analyze the spatiotemporal dynamic evolution of nasopharyngeal carcinoma before and after immunotherapy and during tumor progression, 2\~3 key cell subsets or node molecules were screened to predict the curative effect. Spatial metabolome and organoids were used to elucidate the mechanism of key factors leading to immunotherapy tolerance in NPC and identify new targets for intervention.
816 studies on the registry are indexed under Nasopharyngeal Carcinoma; 282 are open to participants now.
This study's planned enrollment of 600 is above the median of 300 across 135 observational studies indexed under Nasopharyngeal Carcinoma.
Browse Nasopharyngeal Carcinoma studies →Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is the lead sponsor of 160 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with nasopharyngeal carcinoma who were admitted to our hospital
Inclusion Criteria Before the trial, the participants must meet all of the following requirements to be eligible for inclusion.
Exclusion Criteria Before the trial, the participants who meet any of the following requirements cannot be included.
Other: No Intervention
This project involves no therapeutic intervention for the subjects.
Failure-free survival (FFS)
Failure-free survival is measured from day of diagnosis until treatment failure, death from any cause, or last follow-up visit, whichever occurred first
Time frame: 3-year
Overall survival (OS)
Overall survival is measured from day of diagnosis until death due to any cause or the latest known date alive
Time frame: 5-year
No study locations are listed for this record.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology